15 days ago
PFE
AnalystsTrung HuynhTrung Huynh's Stock Forecasts
AnalystsTrung Huynh
Sectors:
Industries:
Analyst Ranking
Top 13%
#593 out of 4866 analysts
Average Return
+20.37%
Win Rate
58%15 out of 26
Risk vs Reward
Poor
Good
Trung Huynh's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Insmed IncINSM | +167.19% | $29.23 | $78.10 | 2024-02-27 - 2025-02-26 | Strong Buy |
Eli Lilly & CoLLY | +85.30% | $395.86 | $733.51 | 2023-04-28 - 2024-04-26 | Buy |
Eli Lilly & CoLLY | +71.55% | $428.44 | $734.97 | 2023-05-04 - 2024-05-03 | Buy |
Eli Lilly & CoLLY | +63.60% | $361.67 | $591.71 | 2022-11-18 - 2023-11-17 | Buy |
Eli Lilly & CoLLY | +60.64% | $526.23 | $845.31 | 2023-08-09 - 2024-08-08 | Buy |
Trung Huynh Analyst Color
Get additional color on Trung Huynh's coverage of popular stocks
2 months ago
INSM
a year ago
INSM
2 years ago
LLY
2 years ago
LLY
2 years ago
JNJ
2 years ago
PFE
2 years ago
LLY
2 years ago
LLY
2 years ago
JNJ
2 years ago
PFE
2 years ago
ABBV
Trung Huynh's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Bristol Myers Squibb CoBMY | 5 | Hold | $54.00 | +8.39% | Maintains | 12 days ago |
Pfizer IncPFE | 5 | Hold | $24.00 | +6.52% | Maintains | 15 days ago |
Cabaletta Bio IncCABA | 2 | Strong Buy | $7.00 | +446.88% | Maintains | 22 days ago |
Insmed IncINSM | 4 | Strong Buy | $110.00 | +54.41% | Maintains | 2 months ago |
Jasper Therapeutics IncJSPR | 1 | Strong Buy | $38.00 | +769.57% | Initiates Coverage On | 2 months ago |
Celldex Therapeutics IncCLDX | 1 | Strong Buy | $44.00 | +126.92% | Initiates Coverage On | 2 months ago |
Regeneron Pharmaceuticals IncREGN | 1 | Hold | $738.00 | +26.05% | Downgrades | 3 months ago |
Kyverna Therapeutics IncKYTX | 1 | Strong Buy | $13.00 | +519.05% | Initiates Coverage On | 6 months ago |
Eli Lilly & CoLLY | 7 | Strong Buy | $710.00 | N/A | Assumes | 2 years ago |
Johnson & JohnsonJNJ | 2 | Hold | $175.00 | N/A | Maintains | 2 years ago |
Amgen IncAMGN | 3 | Buy | $200.00 | N/A | Maintains | 2 years ago |
Merck & Co IncMRK | 3 | Buy | $126.00 | N/A | Maintains | 2 years ago |
Abbvie IncABBV | 1 | Buy | $170.00 | N/A | Initiates Coverage On | 2 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.